The company said its GAAP diluted loss per share was $(0.14) and its adjusted diluted earnings per share (non-GAAP) was $0.58 for Q3 2026. Total revenues were $50,647 million, and premium and service revenues were $45,105 million for Q3.

1. 01

   The company said its GAAP diluted loss per share was $(0.14) and its adjusted diluted earnings per share (non-GAAP) was $0.58 for Q3 2026. Total revenues were $50,647 million, and premium and service revenues were $45,105 million for Q3.

2. 02

   Centene said its consolidated HBR was 92.7% for Q3 2026, unchanged from 92.7% a year earlier. The company attributed this to a lower Marketplace HBR and strong performance in its Medicare Advantage and PDP businesses.

3. 03

   The company said cash flow used in operations was $3.7 billion for Q3, mainly due to the timing of pass-through, premium and other payments. In Q3, it repurchased $558 million of its par value senior notes due 2027 and 2028, and total debt was $15.5 billion.

4. 04

   The company said it is updating its full-year 2026 GAAP diluted EPS guidance floor to greater than $3.46 and its adjusted diluted EPS guidance floor to greater than $5.20. It also said it is decreasing its HBR guidance range to 90.4% to 91.1%.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.